Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06039566 · ClinicalTrials.gov registry record · Phase 3
NAC vs Placebo on Opioid Use for Hysterectomy
A Phase 3 study of Hysterectomy, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT06039566: Recruiting Phase 3 study of Hysterectomy, sponsored by Medical University of South Carolina.
NCT06039566 is a Phase 3 study of Hysterectomy that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 240 participants, above the 110-participant average among 8 other Hysterectomy trials with a reported enrollment target (118% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06039566, a Phase 3 study of Hysterectomy, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll females who are ages 18 and older undergoing a laparoscopic or robotic, partial or full hysterectomy. Participants will be randomized to receive IV n-acetylcysteine or placebo during the first 60 minutes of their procedure. At various time points after the procedure patients will be asked to report their pain scores, and any pain medication taken.
Primary Outcome
72-hour post-medication opioid consumption.
Conditions Studied
Interventions
- DRUG IV N-acetylcysteine
- DRUG IV Placebo
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-11-30 |
| Est. Completion | 2026-12-09 |
| Phase | Phase 3 |
What NCT06039566 shows while recruiting
NCT06039566 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 110-participant average among 8 other Hysterectomy trials with a reported enrollment target (118% higher).
The record links to 1 condition, with Hysterectomy appearing as the primary indexed condition, and to 2 interventions - of which IV N-acetylcysteine is the first listed.
NCT06039566 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06039566 about?
NCT06039566 is a clinical study titled "NAC vs Placebo on Opioid Use for Hysterectomy". This study will enroll females who are ages 18 and older undergoing a laparoscopic or robotic, partial or full hysterectomy. Participants will be randomized to receive IV n-acetylcysteine or placebo during the first 60 minutes of their procedure. At various time points after the procedure patients w...
What is the current status of trial NCT06039566?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2023-11-30. Estimated completion is 2026-12-09.
What conditions does trial NCT06039566 study?
This clinical trial studies the following conditions: Hysterectomy.
What interventions are being tested in trial NCT06039566?
The interventions under investigation include: IV N-acetylcysteine (DRUG), IV Placebo (DRUG).
Who is sponsoring clinical trial NCT06039566?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06039566 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hysterectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06039566's enrollment target sits among peer trials
240 2nd of 8 the highest of 8 other Hysterectomy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hysterectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery
COMPLETED · Phase 3
-
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
RECRUITING · Phase 4
-
Bilateral Oophorectomy Versus Ovarian Conservation
COMPLETED · NA
-
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
COMPLETED · Phase 4
-
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI